Analgesic Effect of Resistance Training for Breast Cancer Survivors ((ANTRAC))
Breast Cancer, Surgery, Chemotherapy Effect
About this trial
This is an interventional treatment trial for Breast Cancer focused on measuring Persistent Pain, Breast cancer treatment, Physical function, Quality of life, Resistance training, Analgesic effect of resistance training of persistent pain after breast cancer (ANTRAC)
Eligibility Criteria
Inclusion Criteria:
- primary diagnosis of breast cancer (grades I-IIIA).
- adult women at least 18 years of age.
- having received breast cancer treatment (i.e. surgery and possible adjuvant chemo and/or radiotherapy) at least 18 months before the start of the study.
- self reported pain in the areas of the breast, shoulder, axilla, arm and/or side of body with an intensity of ≥ 3 on a numeric rating scale (0 = no pain, 10 = worst pain imaginable).
- no signs of cancer recurrence.
- reading, writing and speaking Danish.
Exclusion Criteria:
- breast surgery for cosmetic reasons or prophylactic mastectomy.
- bilateral breast cancer.
- lymphedema.
- other chronic pain conditions (e.g., rheumatoid arthritis).
- previous diagnosis of fibromyalgia syndrome.
Sites / Locations
- Department of Health Science and Technology, Aalborg University
Arms of the Study
Arm 1
Arm 2
Experimental
Other
Training
Control
Participants with persistent pain after breast cancer treatment will receive 24 sessions of individualized progressive total body resistance training, supervised by a certified strength and conditioning specialist.
Participants with persistent pain after breast cancer treatment will be instructed to continue their everyday lifestyle and be encouraged not to engage in new forms of exercise or physical activity throughout the study period.